Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Brain, Behavior, and Immunity|August 14, 2021
Prenatal alcohol-induced sex differences in immune, metabolic and neurobehavioral outcomes in adult ratsShameena Bake, Marisa R Pinson, Sivani Pandey, et al.Brain, Behavior, and Immunity|August 14, 2024
Peripheral, but not central, IGF-1 treatment attenuates stroke-induced cognitive impairment in middle-aged female Sprague Dawley rats: The gut as a therapeutic targetYumna El-Hakim, Kathiresh Kumar Mani, Kaylin A Pickle, et al.Brain, Behavior, and Immunity|November 3, 2022
Intestinal epithelial stem cell transplants as a novel therapy for cerebrovascular strokeKathiresh Kumar Mani, Yumna El-Hakim, Taylor E Branyan, et al.Biorxiv : the Preprint Server for Biology|February 20, 2025
Loss of white matter tracts and persistent microglial activation in the chronic phase of ischemic stroke in female rats and the effect of miR-20a-3p treatmentDayalan Sampath, Macy E Zardeneta, Zara Akbari, et al.Scientific Reports|December 26, 2025
Adriamycin nephropathy induces sensorineural hearing loss via blood-labyrinth barrier breakdown in BALB/c miceAkanksha Gajbhiye, Sheng Jin, Ah-Ra Lyu, et al.Acta Neuropathologica Communications|May 3, 2025
Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cellsLavanya Venkatasamy, Jaclyn Iannucci, Aleksandr Pereverzev, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 19, 2026
Using clinical and thrombus characteristics to predict the etiology of ischemic stroke: An analysis of the INSIGHT registryGraham A Branscom, Carina Seah, Tannishtha Som, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 30, 2016
Considering sex as a biological variable in preclinical researchLeah R Miller, Cheryl Marks, Jill B Becker, et al.Molecular Cancer Therapeutics|April 28, 2025
The anti-FRα antibody-drug conjugate luveltamab tazevibulin demonstrates efficacy in non-small cell lung cancer preclinical models and induces immunogenic cell deathRobert Yuan, Andrew McGeehan, Sihong Zhou, et al.Frontiers in Aging Neuroscience|February 15, 2021
New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular DiseasesJohannes Boltze, Jaroslaw A Aronowski, Jerome Badaut, et al.Pageof 8